ニュース
MHRA is examining whether those affected have a genetic trait that is leaving them at a greater risk of side effects from the ...
Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...
NICE says that in some exceptional circumstances the BMI requirements can drop down to 30, and people from some ethnic ...
Amanda Bynes Ozempic weight loss journey is making headlines as the former Nickelodeon star revealed plans to lose over 40 ...
Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...
The WHO has highlighted Finland as a case study on how increased co-payments for diabetes medicines can raise health costs ...
Investing.com -- Novo Nordisk A/S (NYSE: NVO) stock dropped 2.1% premarket following news that Spain’s health ministry has requested clarification about the company’s obesity awareness campaign, which ...
Diabetes drug Ozempic and weight-loss jab Wegovy may also reduce the risk of dementia, according to a new study. American ...
Interpol cited a concerning rise in demand for unauthorised weight loss drugs and peptide supplements in Europe and other ...
Berger Montague investigates Hims and Hers after stock drops 26% following Novo Nordisk's termination of GLP-1 drug partnership.
Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.
Mumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する